Company profile

Lex Diagnostics Limited

Molecular Diagnostics for Primary Care We are developing a PCR platform that works for urgent care centres, physician office labs and pharmacies. In our view this means a step change in usability and sample to result in 5-7 minutes.

We are revolutionizing point-of-care molecular diagnostics with a step change in speed, sensitivity and cost Our vision is to deliver true-PCR insights to clinicians at the time they are most valuable. In our view this means an answer in 5-7 minutes. Latest news: Ed Farrell appointed as CEO Latest news: Scott O'Brien appointed to LEX